END OF LIFE MEDICINES INFORMATION PACK
|
|
|
- Robert Oliver
- 9 years ago
- Views:
Transcription
1 END OF LIFE MEDICINES INFORMATION PACK Advice on end of life medication is available from the nursing and medical team at St Nicholas Hospice Care - telephone Many drugs used in palliative care (especially drug combinations in syringe driver) are used outside of the product licence or datasheet recommendations. However, there is wide experience of their use in palliative care. The responsibility for prescribing is taken by the prescriber (usually a doctor). Practitioners should be aware when using drugs in a manner which falls outside the product licence specification, and should be able to support their practice e.g. with references. October 2012
2
3 ANTICIPATING END OF LIFE When a patient is Deteriorating day by day Taking only sips of water No longer able to take tablets consistently Mostly bedbound May be drowsy Time is getting short Prognosis days if deteriorating day by day Explain need to focus on comfort measures, ensure analgesia Confirm preferred place of care / death Consider Is ongoing care in current location practical? what else needs to be arranged Who else needs to know / who do they want to see / be around Explain process of dying to relatives increasing drowsiness, withdrawal, body not able to utilise food, reduced ability to swallow Page 1
4 END OF LIFE MEDICINES To ensure common symptoms in the terminal phase eg pain, secretions and agitation are anticipated and can be managed using anticipatory drugs Consider: which medicines can be stopped which need to be continued or replaced (established analgesics, anti-emetics, anticonvulsants) for ongoing symptom control possibly by continuous subcutaneous infusion (CSCI) in a syringe driver many tablets can be prescribed as oral liquids what drugs need to be made available as PRN (as needed) medicines: prescribe and give all injections by subcutaneous route (SC) 5 common medications used in end of life care: ANALGESIC: provides background and breakthrough (as needed) analgesia ANTI EMETIC: continue existing anti-emetic if effective ANTISECRETORY: provide as needed and start CSCI as soon as any rattle starts RELAXANT / SEDATIVE: for agitation ANTICONVULSANT: Midazolam 20-30mg/24hours by CSCI is usually sufficient to manage seizures which have required anticonvulsants Page 2
5 ANALGESICS PRN (as needed) doses equivalent to 1/6 of 24 hour dose given as needed 2-4 hourly The correct dose is that which relieves pain for 4hrs this may be less or more than 4 hourly equivalent. If pain persists increase by 1/3 to 1/2 or guided by PRN doses used. The dose of opioid in a CSCI by syringe driver should be determined by the previous effective dose of medication used by the patient for pain control (regular and breakthrough doses): Guideline 24 hour doses by CSCI (Syringe Driver) On no opioids (eg Paracetamol only) use 5mg - 10mg Morphine or Diamorphine On full dose Codeine (240mg/day) On Morphine On Oxycodone use 20mg - 30mg Morphine or Diamorphine use equivalent dose Morphine 1/2 oral morphine dose) or Diamorphine (1/3 oral Morphine dose) use equivalent dose Oxycodone or Diamorphine (1/2 oral Oxycodone dose) SC Diamorphine and Oxycodone are equivalent mg for mg PATCHES If on Fentanyl patch leave patch in place, replace when due. Page 3
6 If additional pain relief required continue with patch at usual dose and use Diamorphine in syringe driver with dose based either: a) On patient use of breakthrough medication OR b) Calculated as equivalent to 1/3 to 1/2 of Fentanyl patch 24 hour equivalent thus increasing total opioid dose by 30-50% Divide the patch dose by 5 to calculate the 4 hourly SC Diamorphine dose eg 75mcg per hour patch divided by 5 = 15mg SC 4 hourly Diamorphine breakthrough dose. Multiply by 6 for 24 hour dose. See conversion chart. For other opioids use conversion chart or call for advice If indication is renal failure consider using Alfentanil ANTIEMETICS On antiemetic: If patient starting an opioid: Continue current effective antiemetic in similar dose use 2.5mg Haloperidol /24 hours unless contraindicated or 5mg - 10mg Levomepromazine / 24hrs Avoid problems: Consider the potential need to add Hyoscine to syringe driver mix for secretions as Cyclizine and Hyoscine Butylbromide (Buscopan) tend to crystallise thus making the infusion ineffective. If the patient is established on Cyclizine either change to Levomepromazine (5mg-25mg) for nausea or use Glycopyrronium rather than Hyoscine for secretions Page 4
7 ANTISECRETORY give early PRN as needed and continue by adding in to syringe driver Starting an antisecretory in the CSCI as soon as secretions start to be audible can prevent them becoming established. In the last days or hours respiratory secretions often build up and may cause distress to the patient and/or relatives. The key to management is not to let them become established as once they have built up they are difficult to clear. PRN dose: Hyoscine Butylbromide Glycopyrronium 20mg subcutaneously 2-4 hourly 200mcg - 400mcg 2-4 hourly CSCI: Use Hyoscine Butylbromide 60mg - 120mg over 24 hours Or Glycopyrronium 120mcg mcg over 24 hours (1.2mg - 2.4mg over 24 hours) Hyoscine Hydrobromide can be used but is more likely to cause agitation as more crosses the blood-brain barrier. Page 5
8 RELAXATION / SEDATION Many patients become agitated in their last hours or days and this is often the reason why out of hours services are called. Lorazepam 0.5mg - 1mg sublingually, can be given by relatives/carers 2-4 hourly PRN as needed. Midazolam subcutaneously PRN/stat works quickly in minutes and lasts about 2 hours. If agitation is likely to recur; consider adding Midazolam to CSCI. PRN doses: Midazolam is 2.5mg - 5mg 1-2 hourly. Larger doses e.g. 5mg - 10mg Midazolam may be needed if patient already on more than 20mg/24hours in syringe driver. CSCI Starting Doses: Midazolam 10mg - 20mg is usually enough for mild to moderate agitation in a patient not previously on sedatives. Or Levomepromazine 25mg - 75mg. Severely distressed patients, heavy drinkers or those previously on anti psychotics may require higher doses or both agents together (call for advice). If patient already on Benzodiazepine - consider using Midazolam in CSCI If patient already on antipsychotic consider using Levomepromazine in CSCI End of Life Medicines in Parkinson s Disease Drugs to avoid: Haloperidol, Metaclopramide, Levomepromazine, Prochloperazine, Risperidone and Olanzapine all reduce dopamine Do not stop Levodopa suddenly (neuroleptic malignant symdrome) consider dispersible medicines via nasogastric tube or conversion to Rotigitine patch (consult medicines information WSH for dose equivalents) Page 6
9 AMPOULES AVAILABLE Ampoule sizes: Usual doses/24 hours: Cyclizine 50mg in 1ml 150mg Haloperidol 5mg in 1ml 5mg - 10mg for nausea Levomepromazine 25mg in 1ml 5mg - 25mg for nausea Metoclopramide 10mg in 2ml 30mg - 60mg for nausea Midazolam 10mg in 2ml 10mg - 60mg for agitation Hyoscine Butylbromide 20mg in 1ml 60mg - 120mg for secretions Glycopyrronium 200mcg in 1ml 1200mcg mcg for secretions or 600mcg in 3ml Diamorphine Morphine sulphate Oxycodone 5mg, 10mg, 30mg, 60mg, 100mg, 500mg amps 10mg, 15mg, 20mg and 30mg /ml all in 1 and 2ml amps 10mg in 1ml, 20mg in 1ml and 50mg in 1ml amps Page 7
10 Writing a prescription for End of Life Drugs Consider how many days supply is needed enough to cover a weekend and the time needed to arrange further supplies - 3 days minimum, 5 days more comfortable Provide enough for at least 3-4 PRN (as needed) doses per day as well as for CSCI (syringe driver) Prescribe on FP10 to obtain medicines and on Syringe Driver and PRN (as needed) charts. Provide a range of doses, this will allow dose adjustment as required. Complete directions to administer medications for District / Marie Curie / trained nurses and as a guideline for out of hours doctors who may be called. Page 8
11 For example, a CSCI containing: Diamorphine 20mg - 30mg Haloperidol 2.5mg Water for injection Remember to prescribe anticipatory medications for example: Midazolam 10mg - 30mg Hyoscine Butylbromide 60mg - 120mg Remember appropriate PRN (as needed) doses Prescribe on FP10 1. Diamorphine 10mg (ten) ampoules times 15 (fifteen) To be given as 20mg (twenty)/24 hours by CSCI 2. Diamorphine 5mg ampoules (Five mg) times 15 (Fifteen) To be given 2.5mg - 5mg sc 2-4 hourly for pain 3. Haloperidol 5mg amp times 5 To be given as 2.5mg/24 hours by CSCI 4. *Midazolam amp 10mg/2ml (ten in two) times 20 (twenty) * NB now a CD To be given by CSCI at 10mg - 30mg per 24 hours To be given as 2.5mg - 5mg sc 2-4 hourly as needed for agitation 5. Hyoscine Butylbromide 20mg/1ml amp times 20 To be given as 60mg - 120mg/24hours by CSCI And 20mg sc 2-4 hourly as needed for secretions Or 6. Water for injection 10ml amps x % saline 10ml amps x15 8. Ensure supply of syringes, needles and sharps box Starting / Setting Up a Syringe Driver (Graseby) Also complete directions to administer. Page 9
12 Starting / Setting Up a Syringe Driver (McKinley T34) If symptomatic give stat dose as syringe driver takes 2-4 hours from setting up to achieve effect. The McKinley T34 is calibrated in ml/hour A 30ml Luer lock syringe is recommended The maximum volume of fluid in a 30ml syringe is 22ml If a 20ml Luer lock system is used, the maximum volume of fluid in a 20ml syringe is 17ml Lock on volume to be infused over 24 hours To stop syringe driver unlock cassing (key in syringe driver medication box), press Stop key Diluent 0.9% saline (not with Cyclizine) or water for injections (WFI) Site reactions are often less with saline, especially with Levomepromazine If site reactions are a problem separate the drugs into two syringe drivers, or dilute even further, or add 1 mg of Dexamethasone. Consider using a plastic rather than metal cannula. Mixtures to avoid: Cyclizine and saline it will crystallise and stop the infusion Cyclizine and Metoclopramide (antagonistic and incompatible) Cyclizine and Hyoscine (crystallises - often in the night) Metoclopramide and Hyoscine (antagonistic and incompatible) Avoid more than 1mg Dexamethasone combined with other medicines. Page 10
13 Compatible mixtures: Morphine/Diamorphine/Oxycodone are compatible with Haloperidol/Levomepromazine/Midazolam/Hyoscine/Glycopyrronium Dexamethasone doses greater than 1mg should be given alone. For more complex combinations consult database or call for advice. Advice on end of life medication is available from the nursing and medical team at St Nicholas Hospice Care - telephone For further information contact: WSH Pharmacy Palliative Adult Network Guidelines Page 11
14 SYRINGE DRIVER DOSE GUIDANCE FOR OPIOID NAIVE PATIENT For use in community and care homes Please allow dose adjustment to maximise symptom control One, or all of these may be needed and should be available for optimum End of Life care. SYRINGE DRIVER : For administration by continuous subcutaneous infusion Drug Dose Duration Diluent DIAMORPHINE 5mg - 10mg 24 hours Water for injection If required for relief of pain / dyspnoea HALOPERIDOL 2.5mg - 5mg 24 hours Water for injection If required for relief of nausea/vomiting BUSCOPAN 60mg - 120mg 24 hours Water for injection If required for relief of respiratory tract secretions, or as an anti-spasmodic MIDAZOLAM 10mg - 20mg 24 hours Water for injection If required for relief of agitation / terminal restlessness Page 12
15 PRN (AS NEEDED) DOSE medication by subcutaneous injection Drug Dose Frequency Max dose/24h DIAMORPHINE 2.5mg - 5mg 2-4hourly PRN If required for relief of pain / dyspnoea HALOPERIDOL 1mg - 2mg 2-4hourly PRN If required for relief of nausea/vomiting BUSCOPAN 20mg 2-4hourly PRN If required for relief of respiratory tract secretions, or as an anti-spasmodic MIDAZOLAM 2.5mg - 5mg 2 hourly PRN If required for relief of agitation / terminal restlessness LORAZEPAM 1mg tablet 0.5mg - 1mg Sublingual / oral 2-4 hourly PRN 2mg - 3 mg max/24hours for breathlessness or anxiety/agitation whilst waiting for professional support Page 13
16 SYRINGE DRIVER DOSE GUIDANCE FOR PATIENT ALREADY ON OPIOID For use in community and care homes Please allow dose adjustment to maximise symptom control One, or all of these may be needed and should be available for optimum End of Life care. SYRINGE DRIVER: For administration by continuous subcutaneous infusion Drug Dose Range Duration Diluent NaCl / Water 24 hours If required for relief of pain / dyspnoea If required for relief of nausea/vomiting 24 hours 24 hours If required for relief of respiratory tract secretions, or as an anti-spasmodic 24 hours If required for relief of agitation / terminal restlessness Page 14
17 PRN (AS NEEDED) dose medication by subcutaneous injection Drug Dose Frequency Max dose/24h If required for relief of pain / dyspnoea If required for relief of nausea/vomiting If required for relief of respiratory tract secretions, or as an anti-spasmodic If required for relief of agitation / terminal restlessness LORAZEPAM 1mg tablet 0.5mg - 1mg Sublingual / oral 2-4 hourly PRN 2mg - 3 mg max/24hours for breathlessness or anxiety/agitation whilst waiting for professional support Page 15
18 A Guide to Equivalent Doses for Opioid Drugs N.B - this is to be used as a guide rather than a set of definitive equivalences. Most data on doses is based on single dose studies so is not necessarily applicable in chronic use, also individual patients may metabolise different drugs at varying rates. The advice is always to calculate doses using Morphine as standard and to adjust then to suit the patient and the situation. Some of these doses have by necessity been rounded up or down to fit in with the preparations available. 4-hr dose (mg) Oral Morphine 12-hr SR dose (mg) 24-hr total dose (mg) Subcutaneous Morphine 4-hr dose (mg) 24-hr total dose (mg) Subcutaneous Diamorphine (oral morphine/3) 4-hr dose (mg) 24-hr total dose (mg) 4-hr dose (mg) Oral Oxycodone 12-hr SR dose (mg) 24-hr total dose (mg) Subcutaneous Oxycodone (½ - ⅔ oral dose) 4-hr dose (mg) 24-hr total dose (mg) Fentanyl Transdermal Patch Strength (mcg) or Transtec Patch Strength (mcg/hr) Max Dose Sub Cut Page 16
19 INJECTIONS Purpose END OF LIFE DRUGS as agreed by Suffolk PCT Dose range for bolus subcutaneous injection Maximum dose in 24 hours Syringe driver s/c 24 hours CSCI Comments Cyclizine Antiemetic 50mg every 6-8 hrs 150mg 100 or 150mg Use water for injection Diamorphine (Schedule 2 CD) Glycopyrronium Analgesic Anti-secretory agent Starting dose 2.5mg to 5mg every 2 hours See fact sheets or BNF for conversion from other opioid analgesics 200micrograms to 400micrograms every 6 hours No maximum Initially 10mg up to 30mg but varies depending on conversions from oral medications and opiate tolerance In patients needing rapid escalation of doses or doses above 200mg consult a specialist. A diluent (water for injection or sodium chloride 0.9% injection) must be prescribed for diamorphine 2400mcg 1200 up to 2400 micrograms Up to 2.4mg can be given by continuous subcutaneous infusion Haloperidol Antiemetic 0.5mg up to 2.5 once or twice a day Anxiety/agitation 1mg up to 5mg repeat every 30 minutes if required 10mg 20mg 2.5 up to 5mg 2.5 up to 10mg Hyoscine Butylbromide Anti-spasmodic / intestinal colic Bronchial secretions 20mg every 4 hours 120mg 60 up to 120mg Higher with specialist advice 20mg every 4 hours 120mg 60 up to 120mg PTO Page 17
20 Levomepromazine Antiemetic 5mg or 6.25mg once or twice a day Terminal agitation 25mg every 4 hours Start with 12.5mg in elderly patients 12.5mg 37.5 max for anti-emesis 12.5mg Long half life, can be given as a single dose at night if sedation a problem 150mg 25 up to 75mg Higher with specialist advice Midazolam (Schedule 3 CD Jan 08) Lorazepam Anxiety 2.5mg to 5mg every 2 hours Terminal agitation/ confusion Anticonvulsant Breathlessness or anxiety/agitation 2.5mg to 5mg every 2 hours Some need higher doses - get specialist advice 5mg repeated if required 0.5mg to 1mg sublingually 60mg 10 up to 20mg Over 40mg get specialist advice 60mg 10mg gradually titrating up Bolus dose short acting consider infusion by SD Over 40mg /24h get specialist advice 60mg 20 or 30mg The buccal route may be used for patients who are fitting ampoule contents can be used NB Lorazepam if patient not palliative 2-3mg ORAL/SUBLINGUAL for the patient to take whilst waiting for professional support Page 18
21
22 St Nicholas Hospice Care Hardwick Lane, Bury St Edmunds, Suffolk IP33 2QY Tel: Switchboard Community Team Fax: Referrals Office Community Team
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323
Community Pharmacists in NHS Rotherham
SERVICE LEVEL AGREEMENT TO ENABLE COMMUNITY PHARMACISTS IN NHS ROTHERHAM TO PROVIDE PALLIATIVE CARE DRUGS AS LOCAL ENHANCED SERVICE PREPARED BY: NHS Rotherham CCG Medicines Management Team on behalf of
Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013
Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013 Access to palliative care drugs out of hours Agreement set up with local community pharmacy s to hold stock of commonly prescribed
Examples of Good Practice Resource Guide
Examples of Good Practice Resource Guide Just in Case Boxes August 2006 Gold Standards Framework Just in Case Boxes Resource Contents 1. Introduction 2. Gold Standards Framework guidance on developing
Guidelines for the Use of Subcutaneous Medications in Palliative Care
Guidelines for the Use of Subcutaneous Medications in Palliative Care Dec 2009 Review Dec 2011 1 Acknowledgments These guidelines have been adapted for local use with kind permission from NHS Greater Glasgow
Guide to the Pharmacological Management of End of Life (Terminal) Symptoms in Residential Aged Care Residents
Guide to the Pharmacological Management of End of Life (Terminal) Symptoms in Residential Aged Care Residents Residential Aged Care Palliative Approach Toolkit Guide to the Pharmacological Management of
The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
How To Take A Strong Opioid Painkiller
Using strong painkillers for cancer pain This information is an extract from the booklet Controlling cancer pain. You may find the full booklet helpful. We can send you a copy free see page 8. Contents
Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme
Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme 1. This agreement is between NHS England North Midlands (Derbyshire/ Nottinghamshire only) (the Commissioner) Birch
Pain management. The WHO analgesic ladder
Pain management Successful treatment requires an accurate diagnosis of the cause and a rational approach to therapy. Most pains arise by stimulation of nociceptive nerve endings; the characteristics may
A Guide to pain relief medicines For patients receiving Palliative Care
A Guide to pain relief medicines For patients receiving Palliative Care 1 Which pain medicines are you taking? Contents Page No. Amitriptyline 8 Codeine 9 Co-codamol 10 Co-dydramol 11 Diclofenac (Voltarol
Symptom Control and Caring for the Dying Patient: Palliative Care Guidelines 4th Edition
Symptom Control and Caring for the Dying Patient: Palliative Care Guidelines 4th Edition Produced by Kent Palliative Medicine Forum University of Kent May 2010 Midazolam Metoclopramide Levomepromazine
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
Clinical protocol for the use of syringe drivers in palliative care patients (adults)
Clinical protocol for the use of syringe drivers in palliative care patients (adults) These guidelines are written for the use of health care professionals in the Oxford Radcliffe NHS Trust and were produced
OPIOIDS CONVERSION GUIDELINES 2007
Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating
Guidelines for the Use of Naloxone in Palliative Care in Adult Patients
Guidelines for the Use of Naloxone in Palliative Care in Adult Patients Date Approved by Network Governance May 2012 Date for Review May 2015 Changes between Version 1 and 2 1. Guideline background 2.
WITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
Collaborative Care Plan for PAIN
1. Pain Assessment *Patient s own description of pain is the most reliable indicator for pain assessment. Pain intensity to be assessed using the ESAS (Edmonton Symptom Assessment Scale) Use 5 th Vital
Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol
Using a Graseby MS26 Syringe Driver for Continuous Subcutaneous Infusions (CSCI) Protocol Who Division 1 Registered Nursing staff for the purposes of administering and monitoring of infusion Division 2
Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal
Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal Great care is required when prescribing opioids to patients with impaired renal function. Many
Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis)
Guideline for the use of subcutaneous hydration in palliative care (hypodermoclysis) Date Approved by Network Governance September 2012 Date for Review September 2015 Page 1 of 7 1 Scope of Guideline 1.1
Abstral Prescriber and Pharmacist Guide
Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of
Review of Pharmacological Pain Management
Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization
LDU Maths, Stats and Numeracy Support. Metric Conversions
Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than
Guidelines for the use of Methadone for Adults with Pain in Palliative Care
Guidelines for the use of Methadone for Adults with Pain in Palliative Care Date Approved by Network Governance October 2012 Date for Review October 2015 Page 1 of 17 1. Scope of the Guideline 1.1 This
Strong opioids (painkillers) in palliative care what you should know
Strong opioids (painkillers) in palliative care what you should know Patient Information Author ID: JG Leaflet Number: PC 006 Version: 1 Name of Leaflet: Strong opioids (painkillers) in palliative care
All Wales Prescription Writing Standards
All Wales Prescription Writing Standards These standards should be read in conjunction with completing the All Wales Medication Chart e- learning package, available on the Learning@NHSWales internet site
MEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts
MEDICINES MANAGEMENT STANDARD OPERATING PROCEDURE (MMSOP018) Preparation of Medication Administration Record (MAR) Charts Any deviation in practice from this procedure must be discussed with the Community
A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS
SUBCUTANEOUS THERAPY A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS PARTS I. Purposes II. General Information III. Responsibilities IV.
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]
DRUG CALCULATIONS Mathematical accuracy is a matter of life and death. [Keighley 1984] At the end of this practice sheet, you will be able to: Perform simple arithmetical tasks. Accurately calculate drug
Patient information. Using strong Opioids to control your pain
Patient information Using strong Opioids to control your pain Published: April 2013. Date for review: April 2016 Introduction This leaflet explains what strong opioids (pronounced oh-pee-oyds) e are and
Acute management of Parkinson s
Acute management of Parkinson s Fife Parkinson s Service 2013 1 Contents 1. Introduction 2. On admission to hospital 3. If Patient has compromised swallow or is nil by mouth 4. Conversion charts if patient
Epidural Continuous Infusion. Patient information Leaflet
Epidural Continuous Infusion Patient information Leaflet April 2015 Introduction You may already know that epidural s are often used to treat pain during childbirth. This same technique can also used as
Subcutaneous Medications and Palliative Care: A guide for caregivers
Caring Safely at Home palliative care education for caregivers Subcutaneous Medications and Palliative Care: A guide for caregivers Contents Disclaimer 2 Introduction 3 1. FAQ Frequently Asked Questions
Standard Operating Procedure
Standard Operating Procedure Title: Controlled Drugs in Community Services (including Community Hospitals, Community Nursing and Community Units) Prepared by: Rajitha Ramakrishnan Presented to: Care &
GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Version: 2
SH CP 29 GUIDELINES FOR THE USE OF PALIPERIDONE PALMITATE (Xeplion ) Summary: Guidelines for the use of paliperidone palmitate (Xeplion ) Keywords (minimum of 5): (To assist policy search engine) Target
First published in 2006 as Guidelines for syringe driver management in palliative care. Reprinted 2007
Centre for Palliative Care Research and Education Queensland Health First published in 2006 as Guidelines for syringe driver management in palliative care. Reprinted 2007 Second edition 2010 COPYRIGHT
Opioids in Palliative Care- Patient Information Manual
Version 2.0 with MST example Introduction The following pages explain what opioids are and what we think you may want to know about them. There is quite a lot of information here, most of it is based on
Anticipating And Preparing For Predictable Clinical Challenges In The Medical Care Of The Terminally Ill Person Wishing To Die At Home.
Mike Harlos MD, CCFP, FCFP Professor, Faculty of Medicine, University of Manitoba Medical Director, WRHA Palliative Care Sub Program Medical Director, St. Boniface General Hospital Palliative Care Room
CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE
MANAGEMENT CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE Parkinson s Disease is classically determined by the triad or rest tremor (usually starting in one arm) with bradykinesia (slowing of
Opioid Conversion Ratios - Guide to Practice 2013 Updated as Version 2 - November 2014
Opioid s - Guide to Practice 2013 Updated as Version 2 - November 2014 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the
How To Treat An Alcoholic Patient
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam
Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care
Hull & East Riding Prescribing Committee Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care 1. BACKGROUND Patients who are physically dependent
RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND
RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND Monitor patient on the ward to detect trends in vital signs and to manage accordingly To recognise deteriorating trends and request relevant medical/out
Opioid toxicity and alternative opioids. Palliative care fixed resource session
Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher
Pain Management in Palliative and Hospice Care
Pain Management in Palliative and Hospice Care Donna Butler, MSN, ANP-BC, OCN, ACHPN, FAAPM Current Status of Pain Cancer patients at EOL- 54% have pain AIDS with prognosis < 6mons- intense pain Less research
DISTRIBUTION: All Clinical Units JHCH, J1, J2, H1, Oncology Day Stay Unit & J2 Day Stay Unit. JHH Intensive Care Unit and Emergency Department
13.12 PROCEDURE SUBJECT: (This guideline is relevant to inpatient use only) DOCUMENT NUMBER: 13.12 DATE DEVELOPED: May 2013 LAST REVISED DATE: NEW PLANNED REVIEW DATE: November 2017 DISTRIBUTION: All Clinical
SAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
Lanarkshire Palliative Care. Guidelines
Lanarkshire Palliative Care Guidelines Palliative Care Guidelines: Introduction Introduction: Palliative Care Guidelines Third Edition Palliative care aims to improve the quality of life of patients and
Nurses Self Paced Learning Module on Pain Management
Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa
PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program
Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential
Narcotic drugs used for pain treatment Version 4.3
Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the
ABC of palliative care: Principles of palliative care and pain control
Clinical review ABC of palliative care: Principles of palliative care and pain control Bill O'Neill, Marie Fallon Top Introduction Principles of palliative care Principles of managing cancer... Introduction
Oxford University Hospitals. NHS Trust. Oxford Centre for Head and Neck Oncology. Pain Relief. Information for patients
Oxford University Hospitals NHS Trust Oxford Centre for Head and Neck Oncology Pain Relief Information for patients Introduction This booklet has been written to give you information about pain relief.
Opioid Conversion Ratios - Guide to Practice 2013
Opioid s - Guide to Practice 2013 Released 1 st October 2013 2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the Eastern
When calculating how much of a drug is required, working with the formula helps the accuracy of the calculation.
DRUG CALCULATIONS When calculating how much of a drug is required, working with the formula helps the accuracy of the calculation. Always remember this formula: What you want X Quantity it comes in What
Emergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
Yorkshire Cancer Network. North East Yorkshire and Humber Clinical Alliance
Yorkshire Cancer Network and North East Yorkshire and Humber Clinical Alliance A GUIDE TO SYMPTOM MANAGEMENT IN PALLIATIVE CARE Version 5.1 Publication date: February 2012 Review date: February 2014 The
MUSC Opioid Analgesic Comparison Chart
MUSC Opioid Analgesic Comparison Chart Approved by the Pharmacy and Therapeutics Committee (February 2006, November 2009, March 2010, December 2011) Prepared by the MUSC Department of Pharmacy Services
Pharmaceutical care of people requiring palliative care Course activities
Pharmaceutical care of people requiring palliative care Course activities Case Study 1 Mrs Green, a 70 year-old lady, has metastatic carcinoma of the breast (breast cancer with spread to other areas).
Palliative Care The Relief You Need When You re Experiencing the Symptoms of Serious Illness
Palliative Care The Relief You Need When You re Experiencing the Symptoms of Serious Illness Dealing with the symptoms of any painful or serious illness is difficult. However, special care is available
Your A-Z of coping with nausea and vomiting A guide for patients and their carers. We care, we discover, we teach
Your A-Z of coping with nausea and vomiting A guide for patients and their carers We care, we discover, we teach Contents What is this guide about?.... 1 What causes nausea and vomiting?... 1 Some common
Opioid Analgesics. Week 19
Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,
DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES
Serving the people of north east Essex DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES A Programmed Approach - It is essential you read this pack & practice the questions prior to your drug calculation
Policy for the issue of permits to prescribe Schedule 8 poisons
Policy for the issue of permits to prescribe Schedule 8 poisons May 2011 Introduction The Victorian Drugs, Poisons and Controlled Substances (DPCS) legislation sets out certain circumstances when a medical
Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)
Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3) List the different medication effects (p5) List the ways that medications
Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010
Pain Control Aims General principles of pain control Basic pharmacokinetics Case history demo Opioids renal failure John Welsh 8/4/2010 Pain Control Morphine is gold standard treatment for moderate to
Humulin R (U500) insulin: Prescribing Guidance
Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring
How To Get A Tirf
Transmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists Products Covered Under This Program Abstral (fentanyl)
Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment
Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment I ve had breast cancer treatment, and now I m having pain. Does this mean the cancer
Clinical Practice Guidelines: Nurse Practitioner, Palliative Care Service
Clinical Practice Guidelines: Nurse Practitioner, Palliative Care Service Purpose of Role The Nurse Practitioner (NP) will provide comprehensive palliative care management and advanced nursing care in
Getting the best result from Opioid medicine. in the management of chronic pain
Getting the best result from Opioid medicine in the management of chronic pain Your doctor has prescribed you opioid medicine to help you manage your chronic pain. This patient information leaflet gives
Crisis Management in Hospice Patients
Objectives Crisis Management in Hospice Patients Identify common symptoms & crises seen in hospice and palliative care patients and how to treat them both non-pharmacologically and with drug therapy Ellen
POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline
West of Scotland Chronic Non Malignant Pain Opioid Prescribing Guideline This guidance forms part of the West of Scotland Efficiency and Productivity Workstream, Acute Prescribing Group. Clinicians from
OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose
OPIOID CONVERSIONS 1. Converting Short acting Long Acting (IR SR) when pain is well controlled *Use for : CHRONIC pain Pts on scheduled IR opioids pain that recurs before the next dose PP: Can use equianalgesic
!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!
ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or
Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach
Your A-Z of Pain Relief A guide to pain relief medicines We care, we discover, we teach Which pain medicines are you taking? Abstral (see Fentanyl Instant Tablets) Amitriptyline 5 Brufen (see Ibuprofen)
General PROVIDER INITIALS: PHYSICIAN ORDERS
Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs
Benzodiazepine & Z drugs withdrawal protocol
Benzodiazepine & Z drugs withdrawal protocol Rationale The NSF for Older People has highlighted the issues of dependence, sedation and fall in the elderly when taking these types of medications. It has
GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR
GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR INTRODUCTION Intravenous (IV) Fentanyl is a good option for pain management during labour and should be administered in a safe and competent
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN
MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges
Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
DRUG TREATMENT OF ACUTE BEHAVIOURAL DISTURBANCE
DRUG TREATMENT OF ACUTE BEHAVIOURAL DISTURBANCE IN GENERAL ADULT (18 65YRS) PSYCHIATRIC IN-PATIENTS This algorithm is a good practice guideline developed by multidisciplinary staff in NHS Lothian. You
DRUG DOSE CALCULATIONS
FINDING THE ORDERED DOSE The ordered dose is the most simple dosage calculation for the prehospital care provider. In this type of problem, the paramedic is given an order to administer to a patient. There
Pain Medication Taper Regimen Time frame to taper off 30-60 days
Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more
Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer
Controlling Pain Part 2: Types of Pain Medicines for Your Prostate Cancer The following information is based on the general experiences of many prostate cancer patients. Your experience may be different.
Section 2 Solving dosage problems
Section 2 Solving dosage problems Whether your organization uses a bulk medication administration system or a unit-dose administration system to prepare to administer pediatric medications, you may find
SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC
SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC
Southlake Psychiatry. Suboxone Contract
Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to
Naloxone Hydrochloride Injection PRODUCT INFORMATION
Naloxone Hydrochloride Injection PRODUCT INFORMATION DESCRIPTION Naloxone hydrochloride is 17-allyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride; C 19 H 21 NO 4.HCl. It is an off-white powder
Pain relief at home. Information for adult patients
Pain relief at home Information for adult patients 3 Contents Page 3 Page 3 Page 5 Page 7 Page 8 Introduction to pain relief Common pain relief medicines and their side effects More information about pain
